Where does Jeffrey Bird work?

Jeffrey Bird is Founder and Managing Director at Bluebird Ventures and Board director at Forty Seven Inc and Board director at Merganser Biotech.

What check size does Jeffrey Bird write?

Jeffrey Bird typically writes checks of $100K – $5M.

What companies has Jeffrey Bird invested in?

Investments tracked here include Forty Seven, Leyden Labs, Portola Pharmaceuticals, Procyrion, Xoft.

Where did Jeffrey Bird go to school?

Jeffrey Bird studied at IAE Paris - Sorbonne Business School (Master of Business Administration (M.B.A.), Management général); IAE Paris - Sorbonne Business School (DU, Entrepreneuriat / études entrepreneuriales); IGEFI, groupe IFAG (Master DAF et manager d'entreprise, Finance et services de gestion financière).

Jeffrey Bird

Investor

Founder and Managing Director at Bluebird Ventures · Managing Director at Sutter Hill Ventures · Member, Board of Trustees at Stanford University · Investor and Board Member at Helix · Board director at Forty Seven Inc · +1 more

Palo Alto, California

Writes $100K – $5M checks · typically $1.5M

Find your path to Jeffrey

4,254 people in our graph share verified history with Jeffrey — schools, employers, funds. One of them is your warm intro.

Paul KwanunlockedJeffrey: together at Stanford University (2026)

×11Jeffrey: together at Stanford University

About

Jeffrey Bird, MD, PhD, founded and leads Bluebird Ventures and previously spent nearly 20 years as a Managing Director at Sutter Hill Ventures investing in early-stage life sciences. He has served as an investor, CEO, and board member across companies including Verinata Health, GRAIL, Forty Seven, and Portola, and earlier held a 12-year operating career at Gilead Sciences; he holds a bachelor's, MD, and PhD in Cancer Biology from Stanford.

Contact· self-published, not guessed

j•••@bluebirdvc.comreveal

Board director at Forty Seven Inc

Intro paths

→

In turn, Jeffrey can intro founders to Forty Seven Inc's investors below.

Forty Seven Inc's investors · 3

Bluebird VenturesPalo Alto Lightspeed Venture PartnersMenlo Park · $1.7M – $87M checks · since 2015 Sofinnova VenturesMenlo Park · $100K – $15M checks

Co-founders at Forty Seven Inc

Ravindra MajetiDirector

Irving WeissmanDirector

Board director at Merganser Biotech

Intro paths

→

In turn, Jeffrey can intro founders to Merganser Biotech's investors below.

Merganser Biotech's investors · 5

Frazier Healthcare PartnersSeattle · $50M – $400M checks Frazier Life SciencesPalo Alto · since 2015 Novartis Venture FundBasel · $5M – $25M checks Osage University PartnersBala Cynwyd Sutter Hill VenturesPalo Alto · $100K – $5M checks

Experience

StarquestRCCI permanentcurrent2024 — present
StarquestDirectrice Conformitécurrent2023 — present
StarquestAdministration - Gestion - Compliance2014 — 2024PARIS
AdFIConseilConsultant2013 — 2014PARIS
Agence d'Ingéniérie et de Services FiduciairesSecrétaire générale2002 — 2013Paris 16
Paris Chamber of Commerce and Industry - CCIPAttachée de Direction2001 — 2002Paris
CCI France (ex ACFCI)Service international : attachée de direction1998 — 2000Paris
Etude de Maître Alain VERGNAUDAdministration judiciaire : Chargée de dossiers1990 — 1995Paris

Skills & more

Conseil juridique8Rédaction12Relations publiques22Communication19Negotiation8Start-up6Veille stratégique6English9Customer Service9Public Speaking7Strategic Planning5Anglais9

+12 more

PowerPointMicrosoft ExcelResearchTeachingBudgetsEditingChange ManagementService clientMicrosoft WordHTMLWindowsOutlook

Languages Anglais (TOEIC score 865) · Italien, Russe, Allemand

From Jeffrey's professional profile.

Deals · 10

ProcyrionSolo GP

via Bluebird Ventures · filed Feb 2024

Kriya TherapeuticsSolo GP

via Bluebird Ventures · filed Jun 2021

Nutcracker TherapeuticsSolo GP

via Bluebird Ventures · filed Sep 2020

EpiriumSolo GP

via Bluebird Ventures · filed Dec 2019

Forty Seven IncSolo GP

via Bluebird Ventures

GRAILSolo GP

via Bluebird Ventures

MedikineSolo GP

via Bluebird Ventures

HelixSolo GP

via Bluebird Ventures

Portola PharmaceuticalsSolo GP

via Bluebird Ventures

Verinata HealthSolo GP

via Bluebird Ventures

Attribution from SEC filings, press coverage, and firm rosters. Some rows are inferred. Not right? Tell us.

Other disclosed investments

Investor

Forty SevenLeyden LabsXoft

Per curated public sources.

Network1

Eli Casdin

Chief Investment Officer and Founder at Casdin Capital

Investors connected to Jeffrey in public investor directories — a warm-intro map.

Frequently asked questions

Who is Jeffrey Bird?: Jeffrey Bird, MD, PhD, founded and leads Bluebird Ventures and previously spent nearly 20 years as a Managing Director at Sutter Hill Ventures investing in early-stage life sciences. He has served as an investor, CEO, and board member across companies including Verinata Health, GRAIL, Forty Seven, and Portola, and earlier held a 12-year operating career at Gilead Sciences; he holds a bachelor's, MD, and PhD in Cancer Biology from Stanford.
Where does Jeffrey Bird work?: Jeffrey Bird is Founder and Managing Director at Bluebird Ventures and Board director at Forty Seven Inc and Board director at Merganser Biotech.
What check size does Jeffrey Bird write?: Jeffrey Bird typically writes checks of $100K – $5M.
What companies has Jeffrey Bird invested in?: Investments tracked here include Forty Seven, Leyden Labs, Portola Pharmaceuticals, Procyrion, Xoft.
Where did Jeffrey Bird go to school?: Jeffrey Bird studied at IAE Paris - Sorbonne Business School (Master of Business Administration (M.B.A.), Management général); IAE Paris - Sorbonne Business School (DU, Entrepreneuriat / études entrepreneuriales); IGEFI, groupe IFAG (Master DAF et manager d'entreprise, Finance et services de gestion financière).